Drug and Insecticide Resistances among Malaria Parasites and Vectors: Advances in Research and Mitigation Approaches
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Parasitic Pathogens".
Deadline for manuscript submissions: closed (20 September 2022) | Viewed by 8465
Special Issue Editors
Interests: vector borne; parasitic diseases; vector bionomics and control; insecticide resistance; mosquitoes; pesticides
Interests: antimalarial drug resistance and surveillance; operational evaluation of integrated malaria control; HIV epidemiology and vector borne; parasitic diseases
Interests: infectious disease; fever; malaria; diarrhea; drug resistance
Special Issue Information
Dear Colleagues,
Malaria is a parasitic disease caused by Plasmodium parasites and transmitted by the Anopheles mosquito species. Its global burden has substantially decreased between 2000 and 2015, with 68%, 22% and 10% contributions by Long Lasting Insecticidal Nets, Artemisinin Combination Therapies (ACTs) and Insecticide indoor Residual Spraying interventions, respectively. However, the progress toward its elimination is stagnating since 2015, due to biological and operational challenges. Of great concerns is the rapid expansion of parasite resistance to drugs and vector resistance to insecticides, which jeopardize the effectiveness of the treatments and core insecticide-based vector control interventions. Therefore, there is a need for streamlining drug administration with currently available and new drugs, development alternative case management and vector control strategies (e.g., rationalization of ACTs, non-chemical interventions to mitigate drug and insecticide resistances), as well as new resistance diagnostic tools for sustainable parasite and vector surveillance.
This Special Issue is focused on, but not limited to local and global evidence of resistance developments, new tools for resistance detection and monitoring, resistance management strategies, alternative products and interventions, metabolic pathways of drugs and insecticides, molecular basis of resistance, etc. We intend to update the knowledge on the landscape and factors governing the evolution of the resistance threats among malaria parasites and mosquito vectors, and how to sustain malaria control while mitigating the resistance problems. We look forward to your contribution.
Dr. Josiane Etang
Dr. Carole Else Eboumbou Moukoko
Dr. Jean Bernard Lekana-Douki
Dr. Philippe Nwane
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- malaria parasites and vectors
- antimalarial drugs
- mosquito control
- drug and insecticide resistance
- molecular markers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.